IBDEI0RP ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13678,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,13678,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,13679,0)
 ;;=250.60^^90^849^7
 ;;^UTILITY(U,$J,358.3,13679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13679,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,13679,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,13679,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,13680,0)
 ;;=250.70^^90^849^8
 ;;^UTILITY(U,$J,358.3,13680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13680,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,13680,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,13680,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,13681,0)
 ;;=250.01^^90^849^4
 ;;^UTILITY(U,$J,358.3,13681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13681,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,13681,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,13681,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,13682,0)
 ;;=272.0^^90^849^22
 ;;^UTILITY(U,$J,358.3,13682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13682,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,13682,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,13682,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,13683,0)
 ;;=272.1^^90^849^28
 ;;^UTILITY(U,$J,358.3,13683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13683,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,13683,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,13683,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,13684,0)
 ;;=272.2^^90^849^24
 ;;^UTILITY(U,$J,358.3,13684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13684,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,13684,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,13684,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,13685,0)
 ;;=275.42^^90^849^21
 ;;^UTILITY(U,$J,358.3,13685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13685,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,13685,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,13685,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,13686,0)
 ;;=275.41^^90^849^29
 ;;^UTILITY(U,$J,358.3,13686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13686,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,13686,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,13686,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,13687,0)
 ;;=276.7^^90^849^23
 ;;^UTILITY(U,$J,358.3,13687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13687,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,13687,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,13687,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,13688,0)
 ;;=275.2^^90^849^19
 ;;^UTILITY(U,$J,358.3,13688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13688,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,13688,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,13688,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,13689,0)
 ;;=276.0^^90^849^25
 ;;^UTILITY(U,$J,358.3,13689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13689,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,13689,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,13689,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,13690,0)
 ;;=276.1^^90^849^32
 ;;^UTILITY(U,$J,358.3,13690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13690,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,13690,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,13690,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,13691,0)
 ;;=275.3^^90^849^20
 ;;^UTILITY(U,$J,358.3,13691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13691,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,13691,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,13691,2)
 ;;=^93796
